Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart
- PMID: 18440230
- PMCID: PMC2430663
- DOI: 10.1016/j.nmd.2008.03.008
Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart
Abstract
Duchenne muscular dystrophy (DMD; dystrophin-deficiency) causes dilated cardiomyopathy in the second decade of life in affected males. We studied the dystrophin-deficient mouse heart (mdx) using high-frequency echocardiography, histomorphometry, and gene expression profiling. Heart dysfunction was prominent at 9-10months of age and showed significantly increased LV internal diameter (end systole) and decreased posterior wall thickness. This cardiomyopathy was associated with a 30% decrease in shortening fraction. Histologically, there was a 10-fold increase in connective tissue volume (fibrosis). mRNA profiling with RT-PCR validation showed activation of key pro-fibrotic genes, including Nox4 and Lox. The Nox gene family expression differed in mdx heart and skeletal muscle, where Nox2 was specifically induced in skeletal muscle while Nox4 was specifically induced in heart. This is the first report of an altered profibrotic gene expression profile in cardiac tissue of dystrophic mice showing echocardiographic evidence of cardiomyopathy.
Figures





Similar articles
-
Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.Int J Mol Sci. 2021 May 10;22(9):5025. doi: 10.3390/ijms22095025. Int J Mol Sci. 2021. PMID: 34068508 Free PMC article.
-
Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.Stem Cells Transl Med. 2013 Jan;2(1):68-80. doi: 10.5966/sctm.2012-0107. Epub 2012 Dec 27. Stem Cells Transl Med. 2013. PMID: 23283493 Free PMC article.
-
Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.Hum Mol Genet. 2013 Jul 1;22(13):2634-41. doi: 10.1093/hmg/ddt112. Epub 2013 Mar 3. Hum Mol Genet. 2013. PMID: 23459935 Free PMC article.
-
Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.Biomed Res Int. 2014;2014:246195. doi: 10.1155/2014/246195. Epub 2014 Mar 20. Biomed Res Int. 2014. PMID: 24772416 Free PMC article. Review.
-
Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.Hum Mol Genet. 2006 Oct 15;15 Spec No 2(SPEC):R253-61. doi: 10.1093/hmg/ddl180. Hum Mol Genet. 2006. PMID: 16987891 Free PMC article. Review.
Cited by
-
Cardiac Characterization of sgca-Null Mice Using High Resolution Echocardiography.Neurol Int. 2013 Nov 27;5(4):e22. doi: 10.4081/ni.2013.e22. eCollection 2013. Neurol Int. 2013. PMID: 24416486 Free PMC article.
-
Role of the Renin-Angiotensin-Aldosterone System in Dystrophin-Deficient Cardiomyopathy.Int J Mol Sci. 2020 Dec 31;22(1):356. doi: 10.3390/ijms22010356. Int J Mol Sci. 2020. PMID: 33396334 Free PMC article. Review.
-
Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.Sci Rep. 2015 Mar 11;5:8986. doi: 10.1038/srep08986. Sci Rep. 2015. PMID: 25758104 Free PMC article.
-
Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy.Dis Model Mech. 2020 Nov 13;13(11):dmm045559. doi: 10.1242/dmm.045559. Dis Model Mech. 2020. PMID: 33188007 Free PMC article.
-
Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy.Antioxidants (Basel). 2024 Dec 18;13(12):1551. doi: 10.3390/antiox13121551. Antioxidants (Basel). 2024. PMID: 39765879 Free PMC article.
References
-
- Hoffman EP, Brown RH, Kunkel LM. Dystrophin, the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919–928. - PubMed
-
- Gilroy J, Cahalan JL, Berman R, Newman M. Cardiac and pulmonary complications in Duchenne’s progressive muscular dystrophy. Circulation. 1963;27:484–493. - PubMed
-
- De Kermadec JM, Becane HM, Chenard A, Tertrain F, Weiss Y. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. Am Heart J. 1994;127:618–23. - PubMed
-
- Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol. 2005;26:66–72. - PubMed
-
- Gulati S, Saxena A, Kumar V, Kalra V. Duchenne Muscular Dystrophy: Prevalence and Patterns of Cardiac Involvement. Indian J Pediatr. 2005;72:389–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous